[Subcutaneous atrophy following steroid injection in the treatment of trigger finger].
Trigger finger (TF), also known as stenosing tenosynovitis, is a rather common condition that causes entrapment of the flexor tendon at the site of the annular pulley. The accepted first-line treatment for TF is injection of long-acting corticosteroid in the involved flexor tendon sheath. This treatment is characterized by a high success rate and a low level of reported adverse effects in the literature. We report a case of subcutaneous atrophy after steroid injection in the treatment of TF.
Skovbakkevej 43, 8800 Viborg. p.birk.larsen@gmail.com.
Peter Birk
PB
Larsen
Michael Kjelager
MK
Tjørnild
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001284:Atrophy / Q000473:pathology; D005260:Female; D005385:Fingers / Q000473:pathology*; D006801:Humans; D007267:Injections / Q000009:adverse effects*; D008875:Middle Aged; D040521:Subcutaneous Tissue / Q000473:pathology*; D052582:Trigger Finger Disorder / Q000188:drug therapy
D000305:Adrenal Cortex Hormones